Could a common antiviral drug help fight deadly brain cancer?
Disease control
Ongoing
This study tests whether adding the antiviral drug valganciclovir to standard treatment can help people with glioblastoma, an aggressive brain cancer. The drug targets a common virus (CMV) found in most of these tumors, which may make the cancer more aggressive. About 220 adults …
Phase: PHASE2 • Sponsor: Cecilia Soderberg-Naucler • Aim: Disease control
Last updated May 13, 2026 16:01 UTC